-
1 Comment
Sigma Healthcare Limited is currently in a long term downtrend where the price is trading 1.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Sigma Healthcare Limited's total revenue rose by 27.9% to $2B since the same quarter in the previous year.
Its net income has increased by 470.7% to $55M since the same quarter in the previous year.
Finally, its free cash flow fell by 4.8% to $-14M since the same quarter in the previous year.
Based on the above factors, Sigma Healthcare Limited gets an overall score of 3/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
ISIN | AU000000SIG5 |
Sector | Healthcare |
Industry | Medical Distribution |
Market Cap | 36B |
---|---|
PE Ratio | None |
Target Price | 2.6618 |
Dividend Yield | 0.4% |
Beta | 0.15 |
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. The company was founded in 1912 and is headquartered in Clayton, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SIG.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025